Hepatocyte growth factor activator inhibitor 1 (HAI-1) is a membrane-bound multidomain protein essential to the integrity of the basement membrane during placental development and is also important in maintaining postnatal homeostasis in many tissues. HAI-1 is a Kunitz-type serine protease inhibitor, and soluble fragments of HAI-1 with variable lengths have been identified in vivo. The full-length extracellular portion of HAI-1 (sHAI-1) shows weaker inhibitory activity toward target proteases than the smaller fragments, suggesting auto-inhibition of HAI-1. However, this possible regulatory mechanism has not yet been evaluated. Here, we solved the crystal structure of sHAI-1 and determined the solution structure by small-angle X-ray scattering. These structural analyses revealed that, despite the presence of long linkers, sHAI-1 exists in a compact conformation in which sHAI-1 active sites in Kunitz domain 1 are sterically blocked by neighboring structural elements. We also found that in the presence of target proteases, sHAI-1 adopts an extended conformation that disables the auto-inhibition effect. Our results also reveal the roles of non-inhibitory domains of this multidomain protein and explain the low activity of the full-length protein. The structural insights gained here improve our understanding of the regulation of HAI-1 inhibitory activities and point to new approaches for better controlling these activities.
Multidomain proteins usually consist of several well-folded domains connected by linker regions (1) (2) (3) . Such proteins can adopt extended tertiary structures with high interdomain flexibility and dynamics. They can also form a compact structure supported by interdomain interactions, and one example for the latter case is the structure of plasminogen, the zymogen precursor of the primary fibrinolytic protease plasmin (4) , in which the seven domains wrapped up into compact tertiary structure. It is possible that these two types of tertiary structures can be interconvertible, and both interdomain interaction and linkers are likely critical determinants of the structure type and the relative orientation of individual domains (4) . Interdomain linkers tend to have high variability in both length (typically from 2 to 18 amino acid residues) and sequences (5) , as compared with the domains that are often more constricted in these parameters because of requirements of conservation of fold and function. Short linkers are more likely lead to a rigid conformation of multidomain protein. However, the relationship between linkers and the conformational dynamics of multidomain proteins is highly empirical and not well-understood.
Hepatocyte growth factor activator inhibitor 1 (HAI-1) 3 is a membrane-bound multidomain protein containing an extracellular region that consist of a MANEC (motif at N terminus with eight cysteines) PAN/apple-like domain (MANEC or N) (6) , an internal PKD-like domain (I), a Kunitz domain 1 (K1), a low-density lipoprotein receptor class A (LDLRA) domain (L), and a Kunitz domain 2 (K2) followed by a C-terminal singlespan transmembrane region (7) . HAI-1 has been shown to be essential to the integrity of the basement membrane during placental development (8) , because HAI-1-deficient mice died in utero due to placental defects. HAI-1 is also important in maintaining postnatal tissue homeostasis including keratinization of the epidermis (9) , hair development (10) , colonic epithelium integrity (11, 12) , proliferation and cell fate of neural progenitor cells (13) , and tissue injury and repair (14, 15) .
HAI-1 has been demonstrated to inhibit a number of serine proteases, including matriptase, HGFA (16, 17) , hepsin (18) , trypsin (19) , and prostasin (20) . The interaction between HAI-1 and matriptase is critical for tissue morphogenesis and cellular biology. An imbalance in the HAI-1:matriptase ratio results in tumorigenesis (21, 22) . For instance, a mild overexpression of matriptase relative to HAI-1 results in spontaneous squamous cell carcinoma, a phenotype that can be effectively reversed back to wild type by additional expression of HAI-1 (22) . It was reported that embryonic death in mice caused by gene deletion of HAI-1 can be rescued by simultaneous deletion of the matriptase gene (23) . Hence, HAI-1 is thought to have tight functional relationship with matriptase to keep a balanced level of enzyme activity to maintain homeostasis.
At present, no structural information is available for fulllength form of HAI-1 or its similar multidomain target proteases. Previous studies on HAI-1 focused on the HAI-1-MANEC domain (6) , the HAI-1-IK1 fragment (15) , and the HAI-1-K1 domain in complex with either matriptase (serine protease domain (SPD)) (24) or HGFA (serine protease domain) (25) , revealing some of the structural condition of the primary inhibitory interactions of HAI-1 with protease domains. Many questions remain on this multidomain protein: how HAI-1 arranges its domains in respect to tertiary structure; what is the relationship between the overall conformation/tertiary structure and function of HAI-1? Also, how does HAI-1 facilitate matriptase activation and inhibition of enzymatic activity?
In this study, we report the crystal structure of the full-length extracellular domain of HAI-1 (sHAI-1). The structure showed that sHAI-1 has a compact conformation mediated by the MANEC domain and a long but well-ordered linker (residues 354 -374, named 365-linker). The mechanism of sHAI-1 autoinhibition was due to sterically blockage on the active site in Kunitz domain 1. The compact conformation was further confirmed to exist in solution by small-angle X-ray scattering (SAXS). The SAXS also showed that the presence of the target protease caused a dramatic conformational change of the tertiary structure of sHAI-1 to extended conformation. Thus, this study illustrated that the compact conformation of sHAI-1 is not suitable for interacting with target proteases, and conformational transition to the open form is required to inhibit the target proteases. In addition, the long linker does not necessarily lead to an extended structure of a multidomain protein (sHAI-1) but also acts as an adhesive to help HAI-1 adopting an auto-inhibitory conformation.
Results

Auto-inhibition of HAI-1 activity through domain interplay
To determine the contribution of individual domains of HAI-1 for the inhibition of matriptase, we produced the recombinant proteins representing the extracellular part of human HAI-1 with different domain truncations, including the NIK1LK2 (sHAI-1), NIK1L, IK1L, and K1 fragments ( Fig. 1A) . These recombinant soluble proteins were expressed either in Drosophila S2 cells (NIK1LK2, NIK1L, and IK1L) or in Pichia pastoris X-33 cells (for K1). Their inhibitory activities toward matriptase (serine protease domain) were analyzed using a chromogenic substrate-assisted enzymatic assay. The NIK1LK2 construct, including all extracellular domains of HAI-1, is referred to as sHAI-1.
The sHAI-1 was 2-fold less potent than the HAI-1 variant lacking the Kunitz domain 2 (NIK1L) based on results of the half-maximal inhibitory concentration (IC 50 ) measurements ( Fig. 1B ), suggesting that the Kunitz domain 2 somehow restrains the inhibitory activity of sHAI-1. On the other hand, the NIK1L construct was again 690-fold less potent than a construct without the MANEC domain (IK1L), demonstrating that the MANEC domain decreases the inhibitory activity of sHAI-1 even more. The inhibitory capability against matriptase of sHAI-1 was 1060-fold weaker than that of the IK1L fragment, together supporting the possibility that the surrounding domains (both MANEC domain and Kunitz domain 2) have a synergistic effect in regulation of sHAI-1 inhibitory activity.
The Kunitz domain 1, the major inhibitory domain of HAI-1, showed 6-to 7-fold less potent inhibitory capability than IK1L ( Fig. 1B) , consistent with the previous report that the internal and LDLRA domains stimulate Kunitz domain 1 inhibition of matriptase (15) . The results obtained here are consistent with a previous study of Kojima et al. using rat HAI-1 and the full-length rat matriptase (26) . They showed that the deletion of the MANEC domain and the Kunitz domain 2 of rat HAI-1 enhanced the inhibitory activity and that the deletion of internal domain and LDLRA domain weakened the inhibitory activity.
Crystallization and structure determination of sHAI-1
To access the roles of sHAI-1 domains in the auto-inhibition of HAI-1 activities, the crystal structure of sHAI-1 was determined. As a multidomain protein, the long linkers between domains likely increase the flexibility of sHAI-1, posing a challenge on its crystallization ability (24) . We screened more than 1000 crystallization conditions and finally obtained preliminary crystals of sHAI-1. Unfortunately, these crystals diffracted only to 7-8 Å from synchrotron X-ray sources. The crystal was confirmed to contain only sHAI-1 with no sign of degradation by SDS-PAGE analysis of washed crystals ( Fig. 2A ). Following intensive efforts to improve the crystal diffraction including screening of cryoprotectant and pH conditions and soaking with different additives (such as calcium), a data set of a moderate resolution (3.8 Å) was obtained. The structure was then determined by molecular replacement, and 80% of the primary sequence (324 of 406 residues) was built into the final structure. The final model was refined to an R work /R free of 0.25/0.33 (Table  1 ) with reasonable geometry. The MANEC domain, internal domain, Kunitz domain 1, and Kunitz domain 2 were welldefined, where the LDLRA domain was untraceable in the electron density maps and not included in the final model.
Despite the limited resolution, the current structure was highly reliable. The collected X-ray data had good quality with high redundancy (25.2) and strong signal (I/ of 17.47; Table 1 ). The molecular replacement solutions were robust with a translation function score of 10.4 (excess 8.0 usually indicates a definitely correct solution) (27) and a log-likelihood gain of 379.4. In addition, most modeled sHAI-1 residues were represented well in the final electron density map, including the long linker connecting to the Kunitz domain 2 (Fig. 2B ).
Crystal structure of sHAI-1 reveals a compact tertiary structure
In the structure of sHAI-1, the four domains (the MANEC domain, the internal domain, the Kunitz domain 1, and the Kunitz domain 2) cluster into a globule rather than an extended conformation ( Fig. 3A) . These four observed domains are arranged in a tetrahedral manner with the internal domain, the Kunitz domain 1 and the Kunitz domain 2 forming a pocket into which the MANEC domain inserts (Fig. 3B ). The MANEC domain plays a critical role in maintaining the compact conformation of sHAI-1. Electrostatic potential analysis of the inter-The structure of HAI-1 ectodomain nal domain and the Kunitz domain 1 reveals that the positively charged concave surface it creates matches favorably with the negatively charged surface of the MANEC domain ( Fig. 3C) .
Similarly, the negatively charged surface of the Kunitz domain 2 is preferred by the positively charged surface of the MANEC domain opposite to the Kunitz domain 2 (Fig. 3C ). Three The internal domain and Kunitz domain 1 are arranged in a V-shape ( Fig. 3A) , quite similar to the previously published crystal structure of the IK1 fragment (PDB code 5ezd) (15), despite the difference in length of protein constructs and crystal packing environments. This comparison demonstrates that the IK1 has a relatively rigid interdomain interface and thus is also critical for maintaining the compact conformation of sHAI-1.
Kunitz domain 2 appears to be loosely attached to the globule core of sHAI-1 with 4.2% of its surface contacting with the neighboring domains. The LDLRA domain is even more labile to an extent that it is completely disordered and could not be modeled in the current structure.
An interesting feature of the new structure is that a long linker (365-linker, residues 354 -374) between the LDLRA domain and the Kunitz domain 2 is well defined by its strong electron density (Fig. 2B ). The 365-linker wedges between the MANEC domain and Kunitz domain 1 and tethers Kunitz domain 2 onto the protein core. This long linker appears to be crucial for maintaining the compact conformation of sHAI-1. It "glues" the MANEC domain and Kunitz domain 1 together via hydrophobic interactions. Leu 363 and Ile 366 of the 365-linker together with Leu 284 of Kunitz domain 1 cover the hydrophobic patch of MANEC domain (formed by Phe 75 , Leu 101 , Phe 117 , Ile 119 , and Phe 137 ) ( Fig. 3G ). Furthermore, most residues of the 365-linker close to the positively charged P1 site of the Kunitz domain 1 (residue Arg 260 ) are negatively charged ( Fig. 3H ).
Structural basis of HAI-1 auto-inhibition
Using the crystallographic approach, we found sHAI-1 adopting a compact conformation. In this conformation, the key inhibitory residue (Arg 260 , P1) of the Kunitz domain 1 was not fully solvent-exposed. Superposition of the HAI-1-K1⅐ matriptase-SPD complex (24) structure to sHAI-1 by the Kunitz domain 1 alignment illustrates that the access of the target proteases is impeded because of steric hindrance from the neighboring HAI-1 domains. Such steric hindrance stems from three structural elements.
First, the MANEC domain is positioned where it would overlap extensively with matriptase protease domain ( Fig. 4A) , thus limiting the inhibitory activity of sHAI-1 in its compact conformation. Three glycosylation sites of HAI-1 (Asn 66 , Asn 235 , and Asn 523 ) were predicted and located in MANEC domain, internal domain, and the cytoplasmic tail of HAI-1, respectively ( Fig.  1A ). An N-linked glycan moiety in the MANEC domain (Asn 66 ) was clearly visible in the current structure. This N-linked glycan is close to the P1 site with a distance of 8.1 Å (Fig. 4B ). In humans, N-linked glycans can be quite extensive and large molecules (28) , suggesting that the glycan can block an additionally larger surrounding area from protease accessibility. We observed that the deglycosylation of Asn 66 indeed led to stronger inhibitory activities ( Fig. 4 , E-G, and Table 2 ).
Second, the 365-linker is close to the P1 residue (Arg 260 ) and blocks the accessibility of Arg 260 (Fig. 4, A and B) . Third, the Kunitz domain 2 was also found collide slightly with matriptase ( Fig. 4C ) and needs to be moved away before matriptase can access to the inhibitory loop region of the Kunitz domain 1. The slightly collision observed here explains the relatively weaker effect from Kunitz domain 2 in down-regulation of the inhibitory activity of sHAI-1 against matriptase.
HAI-1 has two Kunitz-type domains: Kunitz domain 1 and Kunitz domain 2. Kunitz domain 2 was demonstrated to have potent inhibitory activity against trypsin (29) , although it cannot inhibit HGFA and matriptase (24) . In this compact conformation, the active site (Lys 385 , P1) of Kunitz domain 2 is also not fully exposed to the solvent and is impeded by internal domain and Kunitz domain 1 (Fig. 4D ). It should be emphasized that the active P1 residues in the two Kunitz domains are not totally blocked but remain half-solvent-exposed.
X-ray structure of sHAI-1 was supported by SAXS solution structure
To identify sHAI-1 conformation in solution, we used the SAXS method to determine the overall shape of the sHAI-1. sHAI-1 showed no sign of aggregation at the concentration of 3 mg ml Ϫ1 at pH 7.4. The molecular mass was estimated to be 60 kDa from the experimental SAXS data and was very close to the theoretical value of 54 kDa ( Table 3 ). The radius of gyration (R g ) estimated from the Guinier plot was 30.4 Å, which was in excellent agreement with R g of 31.0 Å obtained from a different plot (pairwise distance distribution P(r) function), demonstrating the high quality of the sHAI-1 SAXS data. The pair-wise distance P(r) distribution also gave a maximal dimension (D max ) of 106 Å (Fig. 5, A  and B) . 
The structure of HAI-1 ectodomain
The ab initio molecular model was constructed from the SAXS data. The envelope of sHAI-1 is shaped like a tadpole with a short tail, demonstrating the compact conformation of sHAI-1. The sHAI-1 crystal structure model can be fitted into the head of this molecular envelope. The LDLRA domain that was missed in the crystal structure was placed to the tail region (Fig. 5E ). The theoretical scattering curve generated from such sHAI-1 model fitted quite well to the experimental curve ( 2 of 3.26 using FoXs) (30) (Fig. 5D ). These results indicated that solution sHAI-1 adopts a compact conformation similar to what we observed in crystals. This is quite interesting considering the loose interaction between the Kunitz domain 2 and the remaining part of sHAI-1 in the presence of the long linker (365-linker). It is difficult to explain the presence of the tail in the SAXS envelop. One possibility might be that this tail reflects the flexibility of the LDLRA domain of the sHAI-1, which can adopt a range of different conformations, leading to its disorder in the crystal structure.
sHAI-1 adopts a non-compact conformation upon matriptase binding
To study the conformation of sHAI-1 bound to target serine proteases, we prepared the molecular complex of sHAI-1 with just the SPD of matriptase (molecular mass ϭ ϳ28 kDa). The molecular mass calculated from the SAXS data was 103 kDa, which was higher than the theoretical value (82.5 kDa). The hydrodynamic radius (R g ) estimated from Guinier plot was 45.9 Å, close to the R g obtained from pair-wise distance distribution function P(r) (43.0 Å) ( Table 3 ). The maximal dimension of the complex was much bigger (D max of 158 Å; Fig. 6,  A and B) than the one of sHAI-1 alone (106 Å), showing that the complex adopts a more extended conformation. The ab initio SAXS model was then constructed, and the resulting molecular envelope of the sHAI-1⅐matriptase complex looked like an elongate rod that is wide in the middle part and narrow at its two ends. Again, this shape demonstrated that sHAI-1 adopts a much more extended conformation in the inhibitory complex.
No crystal structure of the sHAI-1⅐matriptase complex is known yet. To explain the SAXS molecular envelope of the sHAI-1⅐matriptase complex, we manually positioned the largest fragment of sHAI-1⅐matriptase complex, the HAI-1-K1⅐matriptase-SPD complex (24) , to the middle of the envelope and placed the MANEC domain in the larger end, whereas the Kunitz domain 2 was positioned in the smaller end. The internal domain and LDLRA domain can then be positioned accordingly (Fig. 6C) . Taken together, we present a model explaining the conforma- tional transition of sHAI-1 upon binding of matriptase (Fig. 6D ). In this model, the overall conformation of sHAI-1 was in an open state where the structural hindrance imposed by the MANEC domain, 365-linker, and Kunitz domain 2 has been removed, whereas the internal domain and Kunitz domain 1 were still organized in a V-shape and clamped the 60 loop of matriptase (15) , and the Kunitz domain 1 can make tight interactions with matriptase using classical Kunitz-type standard mechanism inhibition (15) .
Discussion
The working model of how HAI-1 forms complex with matriptase
Our structural studies reveal that sHAI-1 adopts a compact and auto-inhibitory conformation mediated by the MANEC domain and the 365-linker. For membrane-bound form of HAI-1, the intact MANEC domain and the 365-linker likely . C, structural clashes between Kunitz domain 2 and matriptase-SPD. D, superimposition of the crystal structure of sHAI-1 with the trypsin⅐Kunitz domain complex (PDB code 4U30) shows the clash between trypsin and the internal domain and the Kunitz domain 1 (red circle). The P1 residue (Lys 385 ) is showed as spheres and colored in purple. E, deglycosylated IK1L shows no difference in the IC 50 values compared with the non-deglycosylated IK1L, which suggests that the potential glycosylation site on Asn 235 does not affect the inhibition of matriptase. F and G, the inhibitory capability of deglycosylated sHAI-1 and NIK1L are stronger than that of the non-glycosylated counterpart, indicating that glycan at Asn 66 decreases the inhibitory activity against matriptase. Table 3 SAXS
parameters for sHAI-1 and sHAI-1⅐matriptase complex
The radii of gyration (R g ) in real space are estimated from the SAXS data using Guinier analysis, and the R g of Reci is obtained from pair-wise distance distribution P(r) function. D max , mass, and mass real are the maximum particle dimensions, molecular mass estimated from I(0), and molecular mass calculated from the sequence, respectively. The 2 value of the fit of D max is given. The structure of HAI-1 ectodomain also maintains a compact and auto-inhibitory conformation and exhibits similar inhibitory activity toward matriptase in vivo (31) . We came up with a working model for HAI-1. HAI-1 is expressed as a membrane-bound form and exists as a compact auto-inhibitory conformation (Fig. 7A) . Membrane-bound HAI-1 can shed into the extracellular milieu primary in the 58-and 40/39-kDa forms. The 58-kDa form is most likely the same as our recombinant sHAI-1 and adopts a compact conformation (31) (Fig. 7A) . The 40/39-kDa form likely consists of the MANEC domain, the internal domain, and Kunitz domain 1, without the 365-linker (32) . The MANEC domain of the 40/39-kDa form likely moves from active site of Kunitz domain 1 (Fig.  7A) , explaining the much higher potency of the 40/39-kDa form in inhibition of its target proteases. In the presence of activated two chain matriptase, sHAI-1 adopts an extended conformation ( Fig. 7B ) so that its Kunitz domain 1 can bind to the SPD of target proteases. It is likely that the non-catalytic domains of matriptase can stimulate the conformational transition of HAI-1 from the compact to open state. This is supported by the fact that HAI-1-NIK1LK2 inhibited the entire extracellular domain more strongly than the SPD alone of matriptase (31) . In addition to the interaction between matriptase-SPD and HAI-1 Kunitz domain 1, the CUB2 domain in matriptase also interacts with the Kunitz domain 2 of HAI-1 (34) . Another previous study has shown that the matriptase LDLR4 domain was located near the SPD domain but opposite of the active site cleft of SPD (35) . However, the validity of this model awaits further validation by biophysical approaches or antibody mapping.
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The role of linkers in multidomain proteins
Linkers can serve as a covalent connection between the domains of a multidomain protein. In addition, linkers can also affect the function of the multidomain protein in various ways (36) . In HAI-1, there are four linkers between the five domains, including the 160-linker (residues 155-165), the 245-linker (residues 241-249), the 310-linker (residues 301-318), and the 365-linker. These linkers are classified into three classes according to their length as short linkers (2-5 residues), medium-sized linkers (6 -15 residues), and long linkers (more than 16 residues) (5). The 245-linker and the 365-linker are well-defined in the electron density maps in the sHAI-1 structure, whereas the electron density of the 160-linker and the 310linker were invisible, and they cannot be modeled.
The 365-linker connecting the LDLRA and the Kunitz domain 2 is quite long (20 residues), and this long linker appears to be a major contributor to the compact conformation of sHAI-1. The long 365-linker tethers spatially separated LDLRA domain and Kunitz domain 2 onto the core of sHAI-1. Furthermore, we observe that the 365-linker appears to sterically obstruct the target proteases binding to the active P1 site. This observation is consistent with a previous report where deletion of the 365-linker enhanced the inhibitory activity of HAI-1 markedly (26) . The critical role of this linker is further supported by its high sequence conservation among known mammalian species (Fig. 8) . Sequence conservation is not a typical phenomenon of linkers in multidomain proteins. In general, the 365-linker acts as a structural scaffold and aids in LDLRA and Kunitz domain 2 looping around Kunitz domain 1 to maintain the compact conformation and regulate the inhibitory activity of sHAI-1.
The 245-linker connects the internal domain to Kunitz domain 1. Unlike the typical random coil conformation of an interdomain linker, this linker is observed in ␣-helix conformation in accordance with a well-defined electron density. This linker conformation helps to maintain a more fixed orientation between the internal domain and Kunitz domain 1 as observed in the current study and a previous study (15) . 
The structure of HAI-1 ectodomain
Unlike the 245-and 365-linkers, both the 160-and 310-linkers were disordered, reflecting their flexible propensities. The flexibility of the 160-linker was also shown by a ϳ15°rotation of helix 3 (residues from 143 to 153), which is next to the 160 linker in the sequence, when compared with the crystal structure of sHAI-1 and the NMR structure of the HAI-1-MANEC domain. In summary, the linkers are not only important to maintain the compact conformation of sHAI-1 but also appear to participate in the overall inhibitory activity regulation. This is also an example showing that longer linkers (e.g. the 365linker) do not necessarily lead to higher conformational freedom of the tertiary structure.
A new mode of Kunitz domain association in a multi-Kunitz domain protein
A unique feature of the current HAI-1 conformation is that the two Kunitz-type domains are separated by a domain in sequence but are spatially closed to each other. The reactive site of Kunitz domain 1 and Kunitz domain 2 are both blocked by neighboring structural elements, which explains why the 58-kDa fragment of HAI-1 (NIK1LK2) is not the most potent inhibitor of serine proteases in vivo. This is different from other inhibitory proteins that contain multiple Kunitz-type domains, where the Kunitz-type domains are linked sequentially and at least one of its Kunitz domains is not interrupted by other domains. Examples of these multi-Kunitz-type domain proteins include 1) tissue factor pathway inhibitor with three Kunitz domains, and the Kunitz domains in the inhibitors are not interrupted by another domain (7, 38) ; 2) bikunin, com-posed of two Kunitz-type domains packed close together with the protease binding site in Kunitz domain 1 exposing to solution, but the protease binding site in the Kunitz domain 2 impeded by Kunitz domain 1 (39); and 3) HAI-2, an inhibitor with high homology to HAI-1 but contained only Kunitz domain 1 and Kunitz domain 2, was reported to inhibit HGFA with Kunitz domain 1 as the functional domain in human, but in mouse the truncated HAI-2 contained only Kunitz domain 2 was also an efficient HGFA inhibitor. Whether the discrepancy results from different domain arrangement of these two Kunitz domains in human and mouse is still unknown (40 -43) . It appears that a special arrangement of Kunitz domains represents a new level of inhibitory activity regulation for multi- Kunitz-type proteins, in addition to the Kunitz domain sequences.
A new way to intervene with matriptase-mediated cancer formation
A lower level of HAI-1 in tumors has been shown to be associated with an overall poor prognosis in several cancers (44) . Additionally, matriptase is consistently overexpressed in a wide variety of human tumors of epithelial origin, and high matriptase levels are correlated with poor clinical outcome. The structural insight gained from the current study and the structure model of sHAI-1 in complex with matriptase-SPD provides a new way to intervene with HAI-1 inhibitory activity. The compact conformation of sHAI-1 disfavors its inhibition of target proteases. Reducing the auto-inhibition may be one way to enhance HAI-1 inhibitory activity. This can be achieved by perturbing the interaction between the 365-linker and Kunitz domain 1 and the MANEC domain.
Experimental procedures
Recombinant protein expression and purification
sHAI-1 (Gly 36 -Pro 441 ) and Kunitz domain 1 was expressed in Drosophila S2 cells and X-33 cells, respectively. Protein purification of sHAI-1 and Kunitz domain 1 was done as described previously (45) . Cloning, expression, and purification of HAI-1-NIK1L (Gly 36 -Ser 370 ) was according to our previous method (24) . To express HAI-1-IK1L (Thr 154 -Ser 370 ), the cDNA was generated by PCR using the full-length cDNA of HAI-1 isoform 2 and cloned into the expression vector pMT/Bip/V5-His-A (Invitrogen). Drosophila expression system (S2 cells) was utilized to generate recombinant HAI-1-IK1L as secreted protein. Protein expression and purification was did the same as sHAI-1. Expression, purification, and refolding of the SPD of matriptase basically followed our previous method (15) . The complex of sHAI-1⅐matriptase was formed by mixing sHAI-1 and matriptase-SPD at a molar ratio of 1:1.5 in 150 mM NaCl and 50 mM Tris⅐HCl, pH 7.4, for half an hour. The mixture was then concentrated and purified by size-exclusion chromatography (Superdex 200). The complex fraction was collected and concentrated to ϳ10 mg ml Ϫ1 for further usage.
Determination of the half-maximal inhibitory concentrations (IC 50 )
IC 50 values of sHAI-1 were measured in the reaction buffer (150 mM NaCl, 20 mM Tris⅐HCl, pH 7.4, and 0.5/1000 Tween 20) . The initial concentration of sHAI-1 was 6 mg ml Ϫ1 and was serially diluted at a ratio of 1:3 using the reaction buffer, and then 10 l of each diluted sample was incubated with matriptase at the room temperature for 10 min in a 96-well polysterene plate. The proteolytic reactions were initiated by adding 40 M Pefachrome tPA (tissue plasminogen activator) to the wells to final volumes of 100 l. The kinetics of p-nitroanilide release was monitored spectrophotometrically at 405 nm for 10 min. Control treatments without sHAI-1 were performed to ensure the activity of matriptase, and treatments in the absence of both sHAI-1 and matriptase were performed to exclude any effects of the reaction buffer. The IC 50 values of NIK1L, IK1L, and Kunitz domain 1 were determined in the same way as for sHAI-1. Deglycosylation of HAI-1 (sHAI-1, NIK1L, and IK1L) was performed by adding a trace amount of deglycosylation enzyme (peptide-N-glycosidase F) into protein samples and incubating at 37°C for ϳ2 h. IC 50 measurements of deglycosylated HAI-1 were completed in the same way as sHAI-1.
SAXS data collection and structural modeling
To study the conformation of sHAI-1 in solution, SAXS data were collected on the BL19U2 Beamline at Shanghai Synchrotron Radiation Facility. The energy range of this beamline is 7-15 keV, and the focus spot size (m 2 @12keV) is 320 ϫ 43 (H ϫ V) with a beam divergence angle of 46 ϫ 27 (H ϫ V). The samples were placed in reusable quartz capillaries at 283 K. All data sets were measured with an exposure time of 1 s. Three concentrations (3, 6, and 9 mg ml Ϫ1 ) protein in 150 mM NaCl and 20 mM Tris⅐HCl, pH 7.4, were prepared and analyzed to ensure a possible monomer state. The SAXS data of sHAI-1 were collected between every two buffers. Averaging of the scattering data and background buffer subtraction were performed using bioSAXS-RAW software (46) . The qualities of the scattering curves were analyzed using the program PRIMUS (47) to ensure there was no obvious aggregation or radiation of the sample. The forward scattering I(0) and radius of gyration (R g ) were determined by Guinier analysis, assuming that they were at very small angles (s Յ 1.3/R g ). The indirect Fourier transform method implemented in the program ScÅtter was used to estimate the pair-wise distance distribution function P(r) and the maximum particle dimensions, D max (48) . Molecular mass was calculated from the SAXSMow2 program (49) . Ab initio modeling was performed using DAMMIF program (50) . At least 10 calculated DAMMIF solutions were performed, aligned, and compared. Subsequently, meaningful shapes were picked up and averaged by DAMAVER program (51) . The SAXS data of the complex of sHAI-1⅐matriptase was also collected and analyzed in the same way as sHAI-1.
Crystallization and data collection of sHAI-1
Using sitting drop vapor diffusion, reproducible crystals were finally obtained in 1.6 M ammonium sulfate, 20% glycerol, and 0.08 M sodium acetate, pH 4.6. These crystals were dipped into a precipitant solution of 1.8 M ammonium sulfate, 0.08 M sodium acetate, pH 4.6, with 25% glycerol and then frozen into liquid nitrogen quickly for X-ray data collection. The diffraction data were collected on the BL18U1 Beamline at Shanghai Synchrotron Radiation Facility.
Structure determination and refinement
The diffraction data were indexed, integrated, scaled, and merged using the xia2 automated data processing pipeline (52) , which utilizes XDS (53) and the CCP4 suite (54) . The crystal structure was solved by Phaser-MR of Phenix (27) , using the published crystal structures of the HAI-1-IK1 fragment (PDB code 5ezd) (15) and the NMR structure of the HAI-1-MANEC domain (PDB code 2msx) (6) as search models. Homology modeling of the LDLRA domain was performed by SWISS-MODEL using the LDLRA domain of low-density lipoprotein receptor as template (PDB code 1f8z) (55) . Kunitz domain 2 was
The structure of HAI-1 ectodomain modeled by the program Sculptor using the structure of the Kunitz domain 1 (PDB code 4isl) as template (24) . Determination of the LDLRA domain and Kunitz domain 2 was also proceeded by MR. Subsequent model building was performed in COOT (56) and refined using Phenix.refine (37, 57) . The atomic coordinates and structure factors have been deposited in the PDB under the accession code 5H7V. All graphic representations were prepared using PyMOL. 
